SCHEMBL25906335

SCHEMBL25906335

Cc1ccc(-c2cc(C(C)C)cc(O)c2O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.48
PTGS1 P23219 2/20 0.48
GABRA1 P14867 1/20 0.48
GABRB2 P47870 1/20 0.48
CACNA1C Q13936 1/20 0.48
BACE1 P56817 1/20 0.41
LDHA P00338 1/20 0.40
LDHB P07195 1/20 0.40
LMNA P02545 2/20 0.40
CHRM1 P11229 1/20 0.40
SLC6A2 P23975 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR2B P41595 1/20 0.40
RPS6KA3 P51812 1/20 0.39
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
RNASEH1 O60930 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8855072 0.84 GABRA1 (0.47) TRPA1PTGS1GABRA1GABRB2CACNA1C
SCHEMBL25906319 0.80 TRPA1 (0.55) TRPA1PTGS1CACNA1CBACE1LDHA
SCHEMBL22888328 0.78 HDAC4 (0.49) TRPA1PTGS1GABRA1GABRB2CACNA1C
SCHEMBL6574657 0.74 BACE1 (0.47) PTGS1BACE1RPS6KA3PON1PTGS2
SCHEMBL6346880 0.73 GABRA1 (0.73) TRPA1PTGS1GABRA1GABRB2CACNA1C
SCHEMBL23050226 0.73 LMNA (0.63) TRPA1PTGS1CACNA1CLDHALDHB
SCHEMBL22319169 0.73 METAP2 (0.50) TRPA1PTGS1GABRA1GABRB2CACNA1C
SCHEMBL15313776 0.73 CA1 (0.47) TRPA1PTGS1GABRA1GABRB2LDHA
SCHEMBL23754720 0.73 BACE1 (0.46) TRPA1PTGS1CACNA1CBACE1LMNA
SCHEMBL16581358 0.72 TRPA1 (0.44) TRPA1PTGS1CACNA1CLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC TRPA1 4291/4885PTGS1 1090/4885GABRA1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.